Research
-
Prescription Opioid Use in General and Pediatric Emergency Departments
Children, adolescents, and young adults treated in pediatric emergency departments are much less likely to be prescribed opioids compared to patients of similar age and ailment treated at general EDs.
Categorized in -
Future Health Dividends for California: Valuing Medical Innovations
Reducing the incidence of four common cancers (breast, colon, lung, and prostate cancer), diabetes and stroke by 50 percent would generate nearly $900 billion in social value for California between 2018 and 2040. Just a 10 percent decline generates $175 billion over the same period.
Categorized in -
Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments
Should Congress reauthorize funding for the Patient-Centered Outcomes Research Institute (PCORI)? Professor William Padula writes the PCORI can generate research relevant for shifting to value-based healthcare.
Categorized in -
Trends in the Use of Skilled Nursing Facility and Home Health Care Under the Hospital Readmissions Reduction Program: An Interrupted Time-series Analysis
Hospitals might be shifting to more intensive post-acute care to avoid readmissions among seniors with pneumonia. At the same time, penalized hospitals’ efforts to prevent readmissions may be keeping higher proportions of their patients in the community.
Categorized in -
Analysis of State-Level Drug Pricing Transparency Laws in the United States
In this letter published in JAMA Network Open, Neeraj Sood and Martha Ryan analyze recently enacted prescription drug pricing laws with a transparency component to determine which were informative and disclosed transaction prices.
Categorized in -
State Drug Pricing Transparency Laws: Numerous Efforts, Most Fall Short
166 recently enacted prescription drug pricing laws were analyzed to identify those that contained price transparency measures. Of these, 35 bills in 22 states include a transparency component, but only 7 were deemed to be informative.
Categorized in -
Data Visualization: State Drug Transparency Laws
States are increasingly enacting price transparency laws designed to provide regulators or the public with more information about how entities in the drug distribution system set prices. The data visualization summarizes the 35 drug pricing transparency bills enacted in states between 2015 and 2018.
Categorized in -
Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017
High and rising launch prices of new cancer drugs have raised American public stakeholder and policy concern. A key policy question is whether the clinical gains offered by these drugs in treating specific cancer indications justify the price increases.
Categorized in -
County-Level Unemployment Rates and Service Intensity in Primary Care Physician Offices for Medicare Patients
Patients change their behavior and the way they interact with the healthcare system in the face of an economic recession, and findings also suggest primary care providers changed their service intensity as a result of the recession.
Categorized in -
The Effect of Old-Age Pensions on Health Care Utilization Patterns and Insurance Uptake in Mexico
Documenting results from a cluster-randomized controlled trial designed to supplement incomes in poor towns among adults 70 or older.